| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.51 | 0.002 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |